Form 4: Veracyte Executive John Leite Reports Stock Transaction
SEC Form 4 Filing
John Leite, Chief Commercial Officer-CLIA of Veracyte, Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On September 2, 2024, John Leite, Chief Commercial Officer-CLIA of Veracyte, Inc., had shares withheld to cover tax obligations.
- A total of 1,315 shares of common stock were withheld at a price of $31.55 per share.
- This transaction did not represent a sale by the reporting person but rather a withholding to satisfy tax obligations related to the vesting of Restricted Stock Units (RSUs).
- The RSUs were granted on September 1, 2022 (1,607 shares) and March 6, 2023 (985 shares).
- Following the transaction, Leite beneficially owns 81,653 shares of Veracyte common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing regarding a stock transaction for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders as it is a routine tax withholding event.
Key Dates
| Date | Description |
|---|---|
| 2022-09-01 | Grant date of 1,607 Restricted Stock Units. |
| 2023-03-06 | Grant date of 985 Restricted Stock Units. |
| 2024-09-02 | Date of the stock transaction (tax withholding). |
| 2024-09-04 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.